![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Veiby
Fondatore presso
ATTOVIA THERAPEUTICS, INC.
Patrimonio netto: 1 $ in data 31/07/2026
Profilo
Petter Veiby is the founder of Attovia Therapeutics, Inc., founded in 2022, serving as Chief Scientific Officer.
Mr. Veiby is currently Director at BiVictriX Therapeutics Plc since 2025.
Former jobs include Senior Director at Millennium Pharmaceuticals, Inc. from 2022 to 2023, Global Head-Biotherapeutics at Millennium Pharmaceuticals, Inc. from 1999 to 2020, and Senior Vice President-Business Development at Immunitas Therapeutics, Inc. in 2022.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/08/2026 | 104.952 ( 0,24% ) | 1 $ | 31/07/2026 |
Posizioni attive di Petter Veiby
| Società | Posizione | Inizio |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Fondatore | 16/12/2022 |
| BIVICTRIX THERAPEUTICS PLC | Direttore/Membro del Consiglio | 01/08/2025 |
Precedenti posizioni note di Petter Veiby
| Società | Posizione | Fine |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/06/2023 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01/11/2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/03/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
85
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
